mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.2 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |